Experiments in the field of biology includes the use of drugs or gene editing or implants which improve the capabilities or qualities of living organisms. This is done by the individuals and their groups working in a scientific research environment or a traditional medical laboratory. Biohacking is managing one's own biology with the combination of nutritional, electronic, and medical technologies. It is also referred to as Do-It-Yourself (DIY) biology. Biohacking has brought out an absolute change in the field of synthetic biology. Biohacking have developed an urge of development and innovation of new products. It combines the aspects of technology and synthetic biology.Laboratory experiments are conducted scientists and research individuals to explore new avenues in biotechnology, genetic engineering, and molecular biology. Biohackers embark on numerous experimentations on the body such as monitoring of the heart rate or insertion of microchips to control the stress level. Biohacking Market Size Worth $52,779.36 Million By 2027
Biohackers have developed and are in the process of developing various products to explore the human body. Some of the remarkable products are smart drugs, microchips, magnetic fingertips, brain sensors, RFID implants, bacterial and yeast strains, body sensors, and smart blood pressure monitor health trackers. Currently, wearable analytic technological devices are available widely. The current generation is have a positive approach towards the Biohacking and its devices. Tracking of the heart rate, steps, blood sugar level, and movement of the body, burning calories or any other metrics, can be termed as Biohacking through analytics. The options in terms of Biohacking to keep track of one’s biological performance are wide ranging, innovative, and ever growing.
Global Biohacking Market: Key Trends
Increasing awareness about Biohacking, rising demand for smart devices and effective drugs, and growing prevalence of chronic diseases are factors expected to drive the global Biohacking market during the forecast period. However, strict regulations that govern the genetic engineering experiments, lack of funds required for research, and lack of expertise as well as cyber security practices are expected to restrain the market during the forecast period.
Biohacking Market Segmentation:
By Type
• Outside biohacking
• Inside biohacking
By Product
• Sensors
• Smart Drugs
• Strains
• Others
By Application
• Synthetic Biology
• Genetic Engineering
• Forensic Science
• Diagnosis & Treatment
• Drug Testing
• Others
By End User
• Pharmaceutical & Biotechnological Companies
• Forensic Laboratories
• Others
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
Global Biohacking Market: Regional Analysis
In terms of region, the global Biohacking market can be segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. North America is expected to be a prominent market for biohacking during the forecast period. The region’s dominance can be attributed to strategic presence of key players in the U.S. and Canada.
Major players included in the Biohacking Market:
• Fitbit, Inc.
• Apple Inc
• Synbiota, Inc.
• The Odin
• HVMN Inc
• Thync Global Inc.
• Moodmetric
• Interaxon Inc.
• Behavioral Tech.
• Modern Alkame
1. Market Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Years Considered for the Study
1.3.2 Market Covered
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2. Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3. Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.3 Competitive Insights
4. Global Biohacking Market Variables, Trends & Scope
4.1. Market Lineage Outlook
4.2. Penetration and Growth Prospect Mapping
4.3. Industry Value Chain Analysis
4.4. Cost Analysis Breakdown
4.5. Technology Overview
4.6. Regulatory Framework
4.6.1. Reimbursement Framework
4.6.2. Standards and Compliances
5. Market Overview
5.1. Market Dynamics
5.1.1. Market Driver Analysis
5.1.1.1. Increasing focus of Biohacking Companies on Brand Protection
5.1.1.2. Untapped Opportunities in Emerging Regions
5.1.2. Market Restraint Analysis
5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
5.1.3. Industry Challenges
5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Biohacking Market Analysis Tools
6.1. Industry Analysis - Porter’s
6.1.1. Supplier Power
6.1.2. Buyer Power
6.1.3. Substitution Threat
6.1.4. Threat from New Entrants
6.1.5. Competitive Rivalry
6.2. Pestel Analysis
6.2.1. Political Landscape
6.2.2. Environmental Landscape
6.2.3. Social Landscape
6.2.4. Technology Landscape
6.2.5. Legal Landscape
6.3. Major Deals And Strategic Alliances Analysis
6.3.1. Joint Ventures
6.3.2. Mergers and Acquisitions
6.3.3. Licensing and Partnership
6.3.4. Technology Collaborations
6.3.5. Strategic Divestments
6.4. Market Entry Strategies
6.5. Case Studies
7. Global Biohacking Market,By Type Historical Analysis and Forecast 2020-2027 (USD Million)
7.1. Outside biohacking
7.2. Inside biohacking
8. Global Biohacking Market,By Product Historical Analysis and Forecast 2020-2027 (USD Million)
8.1. Sensors
8.2. Smart Drugs
8.3. Strains
8.4. Others
9. Global Biohacking Market,By Application Historical Analysis and Forecast 2020-2027 (USD Million)
9.1. Synthetic Biology
9.2. Genetic Engineering
9.3. Forensic Science
9.4. Diagnosis & Treatment
9.5. Drug Testing
9.6. Others
10. Global Biohacking Market,By End User Historical Analysis and Forecast 2020-2027 (USD Million)
10.1. Pharmaceutical & Biotechnological Companies,
10.2. Forensic Laboratories
10.3. Others
11. North America Biohacking Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
11.1. Introduction
11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
11.2.1. U.S.A
11.2.2. Canada
11.2.3. Mexico
11.3. Market Size (USD Million) Forecast for North America 2020-2027
12. Latin America Biohacking Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
12.1. Introduction
12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
12.2.1. Brazil
12.2.2. Venezuela
12.2.3. Argentina
12.2.4. Rest of Latin America
12.3. Market Size (USD Million) Forecast for Latin America 2020-2027
13. Europe Biohacking Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
13.1. Introduction
13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
13.2.1. Germany
13.2.2. U.K
13.2.3. France
13.2.4. Italy
13.2.5. Spain
13.2.6. Russia
13.2.7. Poland
13.2.8. Rest of Europe
13.3. Market Size (USD Million) Forecast for Europe 2020-2027
14. Asia Pacific Biohacking Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
14.1. Introduction
14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
14.2.1. Japan
14.2.2. China
14.2.3. India
14.2.4. Australia and New Zealand
14.2.5. ASEAN
14.2.6. Rest of Asia Pacific
14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
15.1. Introduction
15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
15.2.1. Saudi Arabia
15.2.2. UAE
15.2.3. South Africa
15.2.4. Egypt
15.3. Market Size (USD Million) Forecast for MEA 2020-2027
16. Market Share Analysis and Competitive Landscape
16.1. Global Landscape - Key Players, Revenue and Presence
16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
16.3. Global Emerging Companies
16.4. North America - Market Share Analysis and Key Regional Players
16.5. Europe - Market Share Analysis and Key Regional Players
16.6. Asia Pacific - Market Share Analysis and Key Regional Players
16.7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Types Offered and Financial Layouts)
17.1. Fitbit, Inc.
17.1.1. Company Overview
17.1.2. Type Portfolio
17.1.3. SWOT Analysis
17.1.4. Financial Overview
17.1.5. Strategic Overview
17.2. Apple Inc
17.2.1. Company Overview
17.2.2. Type Portfolio
17.2.3. SWOT Analysis
17.2.4. Financial Overview
17.2.5. Strategic Overview
17.3. Erba Diagnostics Inc. (U.S.)
17.3.1. Company Overview
17.3.2. Type Portfolio
17.3.3. SWOT Analysis
17.3.4. Financial Overview
17.3.5. Strategic Overview
17.4. Trinity Biotech plc (Ireland)
17.4.1. Company Overview
17.4.2. Type Portfolio
17.4.3. SWOT Analysis
17.4.4. Financial Overview
17.4.5. Strategic Overview
17.5. Thermo Fisher Scientific, Inc. (U.S.)
17.5.1. Company Overview
17.5.2. Type Portfolio
17.5.3. SWOT Analysis
17.5.4. Financial Overview
17.5.5. Strategic Overview
17.6. Thync Global Inc.
17.6.1. Company Overview
17.6.2. Type Portfolio
17.6.3. SWOT Analysis
17.6.4. Financial Overview
17.6.5. Strategic Overview
17.7. Moodmetric
17.7.1. Company Overview
17.7.2. Type Portfolio
17.7.3. SWOT Analysis
17.7.4. Financial Overview
17.7.5. Strategic Overview
17.8. Interaxon Inc.
17.8.1. Company Overview
17.8.2. Type Portfolio
17.8.3. SWOT Analysis
17.8.4. Financial Overview
17.8.5. Strategic Overview
17.9. Behavioral Tech.
17.9.1. Company Overview
17.9.2. Type Portfolio
17.9.3. SWOT Analysis
17.9.4. Financial Overview
17.9.5. Strategic Overview
17.10.Modern Alkame.
17.10.1. Company Overview
17.10.2. Type Portfolio
17.10.3. SWOT Analysis
17.10.4. Financial Overview
17.10.5. Strategic Overview